Bovine Embryonic Stem Cell Culture for Stable Pluripotency
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The derivation of stable pluripotent embryonic stem cells (ESCs) in the bovine species has been challenging due to poor derivation efficiencies, limited proliferation capacities, and loss of pluripotency markers, with most reported bovine ESC lines failing common pluripotency tests.
Innovation Solution
A method involving culturing ungulate blastocyst cells or pluripotent cells in a medium containing inactivated feeder cells, Fibroblast Growth Factor 2 (FGF2), inhibitors of Wnt signaling, and optionally Rho-associated coiled-coil kinase (ROCK) inhibitors, with low fatty acid bovine serum albumin and modified TeSR™1 basal medium, to produce stable ungulate ESCs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional culture methods are used for bovine ESC derivation, then the process is simpler, but derivation efficiency is poor and cells lose pluripotency markers
Solution Approach 1:
The patent changes multiple culture parameters simultaneously: adds FGF2 (10-100 ng/mL), adds Wnt signaling inhibitor (10-100 μM), adds ROCK inhibitor (1-10 μM), uses inactivated feeder cells instead of active feeders, and modifies basal medium composition. These parameter changes collectively improve derivation efficiency while maintaining cell pluripotency.
Solution Approach 2:
The patent introduces intermediary substances to mediate cell culture: FGF2 as a growth factor mediator, Wnt signaling inhibitors as pathway modulators, and ROCK inhibitors as cytoskeletal stabilizers. These intermediaries facilitate stable pluripotency maintenance during derivation.
2Productivity
If standard culture conditions are applied, then the procedure is easier to perform, but proliferation capacity is limited
Solution Approach 1:
The patent modifies culture parameters by incorporating FGF2 (10-100 ng/mL) to stimulate proliferation, Wnt inhibitors (10-100 μM) to prevent differentiation, and ROCK inhibitors (1-10 μM) to enhance cell survival. This combination achieves high proliferation capacity while maintaining operational feasibility.
Solution Approach 2:
The patent establishes continuous culture conditions that maintain pluripotency and proliferation simultaneously through sustained presence of FGF2, Wnt inhibitors, and ROCK inhibitors in the culture medium, allowing uninterrupted cell expansion.
3Stability of the object's composition
If conventional ESC culture methods are used, then fewer reagents are required, but pluripotency markers are lost after extensive passages
Solution Approach 1:
The patent changes culture parameters by adding FGF2 (10-100 ng/mL), Wnt signaling inhibitors (10-100 μM), and ROCK inhibitors (1-10 μM) to the culture medium. These parameter changes stabilize pluripotency markers during extensive passages despite using multiple reagents.
Solution Approach 2:
The patent employs intermediary molecules: FGF2 as a proliferation mediator, Wnt inhibitors as differentiation blockers, and ROCK inhibitors as survival promoters. These intermediaries work together to maintain pluripotency marker stability throughout extended culture periods.
Data Source
AI summary
This disclosure provides ungulate embryonic stem cells (ESCs) derived from the inner cell mass of pre-implantation blastocysts or pluripotent cells from embryos. From an agricultural and biomedical perspectives, the derivation of stable ESCs from domestic ungulates is important for genomic testing and selection, genetic engineering, and providing an experimental tool for studying human diseases. Cattle are one of the most important domestic ungulates that are commonly used for food and bioreactors.